Glycoconjugate vaccines to prevent group B streptococcal infections (Q35207531)

7 August 2017

title

Glycoconjugate vaccines to prevent group B streptococcal infections (English)

1 reference

7 August 2017

main subject

streptococcal infection

1 reference

Lawrence C Paoletti

1

1 reference

7 August 2017

Dennis L Kasper

series ordinal

2

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Expert Opinion on Biological Therapy

7 August 2017

published in

1 reference

7 August 2017

volume

3

1 reference

7 August 2017

issue

6

1 reference

7 August 2017

page(s)

975-984

1 reference

Conjugate vaccines against group B Streptococcus types IV and VII.

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Group B streptococcal disease in newborns: a global perspective on prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Intrauterine infection and spontaneous midgestation abortion: is the spectrum of microorganisms similar to that in preterm labor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Neonatal Sepsis and Other Infections Due to Group B Beta-Hemolytic Streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Vaccines to prevent neonatal GBS infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Immunogenicity of polysaccharides from type III, group B Streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Potency of clinical group B streptococcal conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Invasive group B streptococcal disease in Maryland nursing home residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Use of a dynamic in vitro attachment and invasion system (DIVAS) to determine influence of growth rate on invasion of respiratory epithelial cells by group B Streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Invasive Group B Streptococcal Infections in Finland: A Population-based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

Invasive group B streptococcal infections in Sweden: incidence, predisposing factors and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.3.6.975

21 January 2018

Identifiers

DOI

10.1517/14712598.3.6.975

1 reference

7 August 2017

1 reference